KR910020011A - 6-치환된 푸리닐 피페라진 유도체 - Google Patents
6-치환된 푸리닐 피페라진 유도체 Download PDFInfo
- Publication number
- KR910020011A KR910020011A KR1019910008205A KR910008205A KR910020011A KR 910020011 A KR910020011 A KR 910020011A KR 1019910008205 A KR1019910008205 A KR 1019910008205A KR 910008205 A KR910008205 A KR 910008205A KR 910020011 A KR910020011 A KR 910020011A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- effective amount
- lower alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000004885 piperazines Chemical class 0.000 title claims 2
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 41
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 11
- 238000000034 method Methods 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 8
- 239000004480 active ingredient Substances 0.000 claims 8
- 239000003937 drug carrier Substances 0.000 claims 8
- 208000019622 heart disease Diseases 0.000 claims 8
- -1 CF 3 Chemical group 0.000 claims 7
- 125000001475 halogen functional group Chemical group 0.000 claims 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- KPPVNWGJXFMGAM-UUILKARUSA-N (e)-2-methyl-1-(6-methyl-3,4-dihydro-2h-quinolin-1-yl)but-2-en-1-one Chemical compound CC1=CC=C2N(C(=O)C(/C)=C/C)CCCC2=C1 KPPVNWGJXFMGAM-UUILKARUSA-N 0.000 claims 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 3
- QNQJPOXVCNGYIR-UHFFFAOYSA-N 7h-purine;hydrate Chemical compound O.C1=NC=C2NC=NC2=N1 QNQJPOXVCNGYIR-UHFFFAOYSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 3
- 125000001544 thienyl group Chemical group 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- PEQFGXNLBPCOMW-UHFFFAOYSA-N 1-(7h-purin-6-ylsulfanyl)-3-(4-pyridin-2-ylpiperazin-1-yl)propan-2-ol;hydrate Chemical compound O.N=1C=NC=2N=CNC=2C=1SCC(O)CN(CC1)CCN1C1=CC=CC=N1 PEQFGXNLBPCOMW-UHFFFAOYSA-N 0.000 claims 1
- HTYPMIQXADGSKR-UHFFFAOYSA-N 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(7h-purin-6-ylsulfanyl)propan-2-ol Chemical compound COC1=CC=CC=C1N1CCN(CC(O)CSC=2C=3NC=NC=3N=CN=2)CC1 HTYPMIQXADGSKR-UHFFFAOYSA-N 0.000 claims 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- SBUKLPSBNFWJCU-UHFFFAOYSA-N ClIBr Chemical compound ClIBr SBUKLPSBNFWJCU-UHFFFAOYSA-N 0.000 claims 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- RZGNXPCHOLHTKP-UHFFFAOYSA-N [1-(7h-purin-6-ylsulfanyl)-3-(4-pyridin-2-ylpiperazin-1-yl)propan-2-yl] acetate Chemical compound N=1C=NC=2N=CNC=2C=1SCC(OC(=O)C)CN(CC1)CCN1C1=CC=CC=N1 RZGNXPCHOLHTKP-UHFFFAOYSA-N 0.000 claims 1
- ZQMZVOCMPDOOFF-UHFFFAOYSA-N [1-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-3-(7h-purin-6-ylsulfanyl)propan-2-yl] hydrogen sulfate Chemical compound N=1C=NC=2N=CNC=2C=1SCC(OS(=O)(=O)O)CN(CC1)CCN1C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 ZQMZVOCMPDOOFF-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000012312 sodium hydride Substances 0.000 claims 1
- 229910000104 sodium hydride Inorganic materials 0.000 claims 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52762590A | 1990-05-23 | 1990-05-23 | |
| US527,625 | 1990-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR910020011A true KR910020011A (ko) | 1991-12-19 |
Family
ID=24102273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019910008205A Ceased KR910020011A (ko) | 1990-05-23 | 1991-05-22 | 6-치환된 푸리닐 피페라진 유도체 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0458618A1 (enExample) |
| JP (1) | JPH04226986A (enExample) |
| KR (1) | KR910020011A (enExample) |
| CN (1) | CN1031642C (enExample) |
| AU (1) | AU636034B2 (enExample) |
| CA (1) | CA2042944A1 (enExample) |
| FI (1) | FI912486A7 (enExample) |
| HU (1) | HUT57768A (enExample) |
| IE (1) | IE911751A1 (enExample) |
| IL (1) | IL98224A (enExample) |
| MY (1) | MY106167A (enExample) |
| NO (1) | NO179909C (enExample) |
| NZ (1) | NZ238122A (enExample) |
| PT (1) | PT97741B (enExample) |
| TN (1) | TNSN91037A1 (enExample) |
| TW (1) | TW211012B (enExample) |
| ZA (1) | ZA913880B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU648070B2 (en) * | 1990-04-23 | 1994-04-14 | Ortho Pharmaceutical Corporation | Process for preparing optically active isomers of 6-substituted purinyl piperazine derivatives |
| JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
| ATE311884T1 (de) * | 1997-07-12 | 2005-12-15 | Cancer Rec Tech Ltd | Cyclin-abhängige-kinase inhibierende purinderivate |
| ES2329595T3 (es) * | 2004-05-12 | 2009-11-27 | Bayer Cropscience Ag | Regulacion del crecimiento de las plantas. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2334009A1 (de) * | 1973-07-04 | 1975-01-23 | Boehringer Mannheim Gmbh | Purin-derivate sowie verfahren zu ihrer herstellung |
| DE3703633A1 (de) * | 1986-02-14 | 1987-08-20 | Sandoz Ag | Purin-derivate, ihre herstellung und sie enthaltende arzneimittel |
| US4876257A (en) * | 1988-03-03 | 1989-10-24 | Ortho Pharmaceutical Corporation | 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents |
-
1991
- 1991-05-10 NZ NZ238122A patent/NZ238122A/en unknown
- 1991-05-21 MY MYPI91000860A patent/MY106167A/en unknown
- 1991-05-21 CA CA002042944A patent/CA2042944A1/en not_active Abandoned
- 1991-05-21 AU AU77233/91A patent/AU636034B2/en not_active Ceased
- 1991-05-22 PT PT97741A patent/PT97741B/pt not_active IP Right Cessation
- 1991-05-22 HU HU911727A patent/HUT57768A/hu unknown
- 1991-05-22 NO NO911973A patent/NO179909C/no unknown
- 1991-05-22 JP JP3145165A patent/JPH04226986A/ja active Pending
- 1991-05-22 ZA ZA913880A patent/ZA913880B/xx unknown
- 1991-05-22 EP EP91304632A patent/EP0458618A1/en not_active Withdrawn
- 1991-05-22 IE IE175191A patent/IE911751A1/en unknown
- 1991-05-22 IL IL9822491A patent/IL98224A/en not_active IP Right Cessation
- 1991-05-22 FI FI912486A patent/FI912486A7/fi not_active Application Discontinuation
- 1991-05-22 KR KR1019910008205A patent/KR910020011A/ko not_active Ceased
- 1991-05-23 CN CN91103957A patent/CN1031642C/zh not_active Expired - Fee Related
- 1991-05-23 TN TNTNSN91037A patent/TNSN91037A1/fr unknown
- 1991-07-25 TW TW080105785A patent/TW211012B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04226986A (ja) | 1992-08-17 |
| NZ238122A (en) | 1994-01-26 |
| EP0458618A1 (en) | 1991-11-27 |
| AU7723391A (en) | 1991-11-28 |
| PT97741A (pt) | 1992-02-28 |
| AU636034B2 (en) | 1993-04-08 |
| NO179909C (no) | 1997-01-08 |
| MY106167A (en) | 1995-03-31 |
| FI912486L (fi) | 1991-11-24 |
| NO911973L (no) | 1991-11-25 |
| NO179909B (no) | 1996-09-30 |
| NO911973D0 (no) | 1991-05-22 |
| CA2042944A1 (en) | 1991-11-24 |
| PT97741B (pt) | 1998-10-30 |
| ZA913880B (en) | 1993-01-27 |
| IL98224A0 (en) | 1992-06-21 |
| FI912486A7 (fi) | 1991-11-24 |
| IE911751A1 (en) | 1991-12-04 |
| HUT57768A (en) | 1991-12-30 |
| CN1031642C (zh) | 1996-04-24 |
| TW211012B (enExample) | 1993-08-11 |
| FI912486A0 (fi) | 1991-05-22 |
| IL98224A (en) | 1995-07-31 |
| CN1057463A (zh) | 1992-01-01 |
| TNSN91037A1 (fr) | 1992-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3271269D1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
| KR890014538A (ko) | 6-치환된 퓨리닐 피페라진 유도체 | |
| DK151627C (da) | Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf. | |
| ES8503667A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina. | |
| DE3475302D1 (en) | Carbacyclins, process for their manufacture and their use as pharmaceutical compounds | |
| EA200101224A1 (ru) | Производные пурина, способ их получения и содержащие их фармацевтические композиции | |
| ES436315A1 (es) | Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alquinilaminopropanos. | |
| KR890014542A (ko) | 4-치환된 피라졸로[3,4-d] 피리미딘 유도체 | |
| ES8704917A1 (es) | Procedimiento para prepararar derivados de 1-piperazinacarboximida. | |
| KR910020011A (ko) | 6-치환된 푸리닐 피페라진 유도체 | |
| KR860008973A (ko) | 2-피롤리돈 유도체 | |
| DK160686D0 (da) | Tri- og tetracycliske forbindelser | |
| KR840006985A (ko) | N-치환플라본-8-카르복사미드유도체 및 그 제조방법 | |
| KR910020007A (ko) | 3-[1-티아졸리디닐부틸-4-피페라지닐]-1h-인다졸, 이의 제조방법 및 이의 약제로서의 용도 | |
| ATE104294T1 (de) | Antipsychotische verbindungen. | |
| ES2111086T3 (es) | Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos. | |
| ZA918991B (en) | Imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them | |
| HU895522D0 (en) | Process for the preparation of new thienyl-oxy-alkyl-amine derivatives and pharmaceutical compositions containing them | |
| KR910011839A (ko) | 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제 | |
| DE3873170D1 (de) | Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums. | |
| KR890005078A (ko) | 벤조푸란 유도체 및 이의 제조방법 | |
| KR920003970A (ko) | 혈중 요산 함량의 강하 방법 | |
| DE3770117D1 (de) | Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3-phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| MY102275A (en) | Antimykotische aminoazole ii | |
| KR900018063A (ko) | 하이드라지노카보닐옥시랍단, 이의 제조방법 및 약제로서의 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19910522 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19960522 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19910522 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19980825 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19981031 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19980825 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |